Connecting the Dots in Early Drug Discovery at Novartis
By Jocelyn Hoppa
June 20, 2018|Reading time: 17 minutes
Editor’s Note: This presentation was given by Stephan Reiling at GraphConnect San Francisco in October 2016. Presentation Summary In this talk, Senior Scientist Stephan Reiling describes some of the ways that a major pharmaceutical company conducts the search for medical… Read more →
Explore: association rule mining • Big Data • biological knowledge • biomedical research • drug discovery • graph technology • graphconnect • heterogeneous data • Novartis • PubMed